Search Results - "Surkont, Michael"

A Systematic Analysis of the Off-Label Use of Bevacizumab for Severe Retinopathy of Prematurity by Micieli, Jonathan A, Surkont, Michael, Smith, Andrew F

“…Purpose To examine the quality of evidence and the variability in the off-label use of bevacizumab (Avastin; Genentech Inc, South San Francisco, California,…”
Get full text

Vacuolar H(+)-ATPase subunits Voa1 and Voa2 cooperatively regulate secretory vesicle acidification, transmitter uptake, and storage by Saw, Ner Mu Nar, Kang, Soo-Young Ann, Parsaud, Leon, Han, Gayoung Anna, Jiang, Tiandan, Grzegorczyk, Krzysztof, Surkont, Michael, Sun-Wada, Ge-Hong, Wada, Yoh, Li, Lijun, Sugita, Shuzo

“…The Vo sector of the vacuolar H(+)-ATPase is a multisubunit complex that forms a proteolipid pore. Among the four isoforms (a1-a4) of subunit Voa, the…”
Get full text

Pediatric eye injuries in a Canadian emergency department by Podbielski, Dominic W., MD, Surkont, Michael, Tehrani, Nasrin N., MB BCh, MSc, FRCS Ed (Ophth), Ratnapalan, R. Savithiri, MBBS, MEd, MRCP, FRCPC, FAAP

“…Abstract Objective: This study assesses the descriptive epidemiology of children with eye injuries presenting to the emergency department of a major Canadian…”
Get full text

Question: Can you identify this condition? by Micieli, Jonathan A., Surkont, Michael, Cohen, Shawn L.

Get full text

Answer: Can you identify this condition? by Micieli, Jonathan A., Surkont, Michael, Cohen, Shawn L.

Get full text

Ophthaproblem: Can you identify this condition? by Micieli, Jonathan A, Surkont, Michael, Cohen, Shawn L

Get full text

Ophthaproblem: can you identify this condition? Diagnosis: Ocular hypertension by Micieli, Jonathan A, Surkont, Michael, Cohen, Shawn L

Get full text